highly significantp = 0.028
Tumor size emerged as the most robust predictor of metastatic disease in our GEP-NET cohort, showing highly significant correlations with lymph node metastases ( p = 0.028), distant metastases ( p < 0.001), and all metastases ( p < 0.001) ( Table 4 ).